ISG15 and non-small cell lung carcinoma: Furthermore, elevated expression of SIRT1 and ISG15 in NSCLC tumors was strongly associated with poor prognosis, suggesting that SIRT1 ISGylation is of potential prognostic value in NSCLC patients.